Biomarin Pharmaceutical
BMRN
Reported
Wednesday, February 19
Q4 2024 Earnings
| (USD) | Expected | Reported | Surprise $ | Surprise % |
|---|---|---|---|---|
| EPS | 0.74 | 0.92 | 0.18 | 24.32% |
| Revenue | 711M | 747M | 36.0M | 5.06% |
WhatIF - Earnings
EPS Beat Expectations by $0.18
Biomarin Pharmaceutical (BMRN:NASDAQ) has never beaten EPS by this much before
There’s a first time for everything